Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Simulations Plus
AddedFeb 19, 2024
UpdatedJun 18, 2026
Simulations Plus

Simulations Plus

Public

California-based Simulations Plus, Inc. provides ADMET modeling software and clinical trial data analysis for various industries.

HQ
Lancaster, CA, US
Founded
1996
Overview
Compare
Fundraising
Employees
Website

Simulations Plus, Inc., based in Lancaster, California, develops advanced ADMET modeling and simulation software for the pharmaceutical, biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. The company also offers clinical trial data analysis and consulting services, particularly through its acquisition of Cognigen Corporation in 2014. Their mission is to translate complex scientific data into user-friendly software solutions that support drug discovery, clinical development research, and regulatory submissions.

Simulations Plus has established itself as a thought leader in ADMET property prediction, physiologically-based pharmacokinetics (PBPK) modeling, pharmacometrics, and quantitative systems pharmacology/toxicology. Their software and consulting services have significantly impacted clients' success in drug development and regulatory processes. The company's expertise and innovative solutions have made it a trusted partner in the scientific community, driving advancements in various industries.

Simulations Plus - Similar Companies

SimQuest logo

SimQuest

simquest.com

QSimulate logo

QSimulate

RealVue Simulation Technologies logo

RealVue Simulation Technologies

SimX logo

SimX

simxvr.com

Simio logo

Simio

simio.com

SimSpace logo

SimSpace

simspace.com

Simpetus logo

Simpetus

SimInsights logo

SimInsights

siminsights.com

EquitySim logo

EquitySim

Pasteur Labs logo

Pasteur Labs

simulation.science

SimVentions logo

SimVentions

simventions.com

Flexcompute logo

Flexcompute

flexcompute.com

Simudyne logo

Simudyne

simudyne.com

Coreform logo

Coreform

coreform.com

Medical Simulation logo

Medical Simulation

Simulations Plus - Quick Facts

Who are Simulations Plus' competitors?

Companies similar to Simulations Plus include SimQuest, QSimulate, RealVue Simulation Technologies and SimX.

When was Simulations Plus founded?

Simulations Plus was founded in 1996.

Where is Simulations Plus' headquarters located?

Simulations Plus' headquarters is located in Lancaster, CA, US.

When was Simulations Plus' last funding round?

Simulations Plus' most recent funding round was for $1.7M (USD) in March 2022.

How much has Simulations Plus raised to-date?

As of Mar 29, 2022, Simulations Plus has raised a total of $1.7M (USD).

How many employees does Simulations Plus have?

Simulations Plus has 163 employees as of Feb 6, 2024.

Simulations Plus - Classification

Ownership
  • Public
Technology
  • AI
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Software
Tags
  • Biotech
Unique IDs
  • ein: 954595609
  • secCik: 0001023459
  • ticker: SLP
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541512Computer Systems Design Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
SIC
  • 7373Computer Integrated Systems Design
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
ISIC
  • 6202Computer consultancy and computer facilities management activities
Show 6 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 6000Depository Institutions
  • 7372Prepackaged Software